Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.

Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.

J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1055-1063. doi: 10.1515/jpem-2019-0006.

PMID:
31573958
2.

A delayed diagnosis of salt-wasting congenital adrenal hyperplasia.

Pijnenburg-Kleizen KJ, Noordam C, Otten BJ, Claahsen-van der Grinten HL.

Clin Endocrinol (Oxf). 2016 Sep;85(3):497-9. doi: 10.1111/cen.13108. Epub 2016 Jun 14. No abstract available.

PMID:
27197923
3.

Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.

Freriks K, Verhaak CM, Sas TC, Menke LA, Wit JM, Otten BJ, de Muinck Keizer-Schrama SM, Smeets DF, Netea-Maier RT, Hermus AR, Kessels RP, Timmers HJ.

Horm Behav. 2015 Mar;69:59-67. doi: 10.1016/j.yhbeh.2014.12.008. Epub 2015 Jan 3.

PMID:
25562712
4.

Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT.

Reus L, Pillen S, Pelzer BJ, van Alfen-van der Velden JA, Hokken-Koelega AC, Zwarts M, Otten BJ, Nijhuis-van der Sanden MW.

Pediatrics. 2014 Dec;134(6):e1619-27. doi: 10.1542/peds.2013-3607.

PMID:
25422026
5.

Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.

de Groot MJ, Pijnenburg-Kleizen KJ, Thomas CM, Sweep FC, Stikkelbroeck NM, Otten BJ, Claahsen-van der Grinten HL.

Clin Chem Lab Med. 2015 Feb;53(3):461-8. doi: 10.1515/cclm-2014-0375.

PMID:
25283138
6.

Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.

Verver EJ, Freriks K, Sas TC, Huygen PL, Pennings RJ, Smeets DF, Hermus AR, Menke LA, Wit JM, Otten BJ, van Alfen-van der Velden JA, de Muinck Keizer-Schrama SM, Topsakal V, Admiraal RJ, Timmers HJ, Kunst HP.

Otol Neurotol. 2014 Oct;35(9):1577-84. doi: 10.1097/MAO.0000000000000406.

PMID:
25133471
7.

Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.

Sas TC, Gault EJ, Bardsley MZ, Menke LA, Freriks K, Perry RJ, Otten BJ, de Muinck Keizer-Schrama SM, Timmers H, Wit JM, Ross JL, Donaldson MD.

Horm Res Paediatr. 2014;81(5):289-97. Review.

8.

Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome.

Schrier L, de Kam ML, McKinnon R, Che Bakri A, Oostdijk W, Sas TC, Menke LA, Otten BJ, de Muinck Keizer-Schrama SM, Kristrom B, Ankarberg-Lindgren C, Burggraaf J, Albertsson-Wikland K, Wit JM.

Horm Res Paediatr. 2014;81(5):319-30. doi: 10.1159/000357844. Epub 2014 Apr 23.

9.

Splice site mutations in GH1 detected in previously (Genetically) undiagnosed families with congenital isolated growth hormone deficiency type II.

Kempers MJ, van der Crabben SN, de Vroede M, Alfen-van der Velden J, Netea-Maier RT, Duim RA, Otten BJ, Losekoot M, Wit JM.

Horm Res Paediatr. 2013;80(6):390-6. doi: 10.1159/000355403. Epub 2013 Nov 23.

PMID:
24280736
10.

Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal mosaicism and Y chromosomal derivatives in patients with Turner syndrome.

Freriks K, Timmers HJ, Netea-Maier RT, Beerendonk CC, Otten BJ, van Alfen-van der Velden JA, Traas MA, Mieloo H, van de Zande GW, Hoefsloot LH, Hermus AR, Smeets DF.

Eur J Med Genet. 2013 Sep;56(9):497-501. doi: 10.1016/j.ejmg.2013.07.008. Epub 2013 Aug 9.

PMID:
23933507
11.

Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.

Reus L, Pelzer BJ, Otten BJ, Siemensma EP, van Alfen-van der Velden JA, Festen DA, Hokken-Koelega AC, Nijhuis-van der Sanden MW.

Res Dev Disabil. 2013 Oct;34(10):3092-103. doi: 10.1016/j.ridd.2013.05.043. Epub 2013 Jul 22.

PMID:
23886754
12.

Objective evaluation of muscle strength in infants with hypotonia and muscle weakness.

Reus L, van Vlimmeren LA, Staal JB, Janssen AJ, Otten BJ, Pelzer BJ, Nijhuis-van der Sanden MW.

Res Dev Disabil. 2013 Apr;34(4):1160-9. doi: 10.1016/j.ridd.2012.12.015. Epub 2013 Feb 1.

PMID:
23380578
13.

Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.

Freriks K, Sas TC, Traas MA, Netea-Maier RT, den Heijer M, Hermus AR, Wit JM, van Alfen-van der Velden JA, Otten BJ, de Muinck Keizer-Schrama SM, Gotthardt M, Dejonckere PH, Zandwijken GR, Menke LA, Timmers HJ.

Eur J Endocrinol. 2012 Dec 10;168(1):91-9. doi: 10.1530/EJE-12-0404. Print 2013 Jan.

PMID:
23076845
14.

Meier-Gorlin syndrome: growth and secondary sexual development of a microcephalic primordial dwarfism disorder.

de Munnik SA, Otten BJ, Schoots J, Bicknell LS, Aftimos S, Al-Aama JY, van Bever Y, Bober MB, Borm GF, Clayton-Smith J, Deal CL, Edrees AY, Feingold M, Fryer A, van Hagen JM, Hennekam RC, Jansweijer MC, Johnson D, Kant SG, Opitz JM, Ramadevi AR, Reardon W, Ross A, Sarda P, Schrander-Stumpel CT, Sluiter AE, Temple IK, Terhal PA, Toutain A, Wise CA, Wright M, Skidmore DL, Samuels ME, Hoefsloot LH, Knoers NV, Brunner HG, Jackson AP, Bongers EM.

Am J Med Genet A. 2012 Nov;158A(11):2733-42. doi: 10.1002/ajmg.a.35681. Epub 2012 Sep 28.

PMID:
23023959
15.

Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study.

Siemensma EP, van Alfen-van der Velden AA, Otten BJ, Laven JS, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1766-73. doi: 10.1210/jc.2012-1595. Epub 2012 Jun 21.

PMID:
22723315
16.

The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review.

Reus L, van Vlimmeren LA, Staal JB, Otten BJ, Nijhuis-van der Sanden MW.

Neurosci Biobehav Rev. 2012 Sep;36(8):1817-38. doi: 10.1016/j.neubiorev.2012.05.005. Epub 2012 May 28. Review.

PMID:
22652271
17.

Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.

Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Vreuls RC, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Willem Pilon J, Lunshof LB, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2012 Jul;97(7):2307-14. doi: 10.1210/jc.2012-1182. Epub 2012 Apr 16.

PMID:
22508707
18.

Absence of clinically relevant growth acceleration in untreated children with non-classical congenital adrenal hyperplasia.

Pijnenburg-Kleizen KJ, Borm GF, Otten BJ, Schott DA, van den Akker EL, Stokvis-Brantsma WH, Voorhoeve PG, Bakker B, Claahsen-van der Grinten HL.

Horm Res Paediatr. 2012;77(3):164-9. doi: 10.1159/000337217. Epub 2012 Apr 12.

PMID:
22508177
19.

Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population.

Sanches SA, Wiegers TA, Otten BJ, Claahsen-van der Grinten HL.

Int J Pediatr Endocrinol. 2012 Feb 2;2012(1):2. doi: 10.1186/1687-9856-2012-2.

20.

Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones.

Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2012 Mar;97(3):E452-9. doi: 10.1210/jc.2011-1954. Epub 2011 Dec 21.

PMID:
22188746
21.

Cardiac evaluation in children with Prader-Willi syndrome.

Marcus KA, van Alfen-van der Velden JA, Otten BJ, Weijers G, Yntema HG, de Korte CL, Kapusta L.

Acta Paediatr. 2012 May;101(5):e225-31. doi: 10.1111/j.1651-2227.2011.02570.x. Epub 2012 Jan 10.

PMID:
22181352
22.

Prepubertal unilateral gynecomastia: a report of two cases.

Hoevenaren IA, Schott DA, Otten BJ, Kroese-Deutman HC.

Eur J Plast Surg. 2011 Oct;34(5):395-398. Epub 2010 Jul 27.

23.

Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome.

Freriks K, Timmermans J, Beerendonk CC, Verhaak CM, Netea-Maier RT, Otten BJ, Braat DD, Smeets DF, Kunst DH, Hermus AR, Timmers HJ.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1517-26. doi: 10.1210/jc.2011-0346. Epub 2011 Jul 13.

PMID:
21752892
24.

Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood.

Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ, Hermus AR.

Pharmacol Ther. 2011 Oct;132(1):1-14. doi: 10.1016/j.pharmthera.2011.05.004. Epub 2011 May 18. Review.

PMID:
21635919
25.

Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome.

Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2011 Jul;75(1):83-9. doi: 10.1111/j.1365-2265.2011.03989.x.

PMID:
21521261
26.

[Adrenal cortex insufficiency in children due to inhaled corticosteroids].

Eijkemans M, Otten BJ, Yntema JB.

Ned Tijdschr Geneeskd. 2011;155:A2862. Dutch.

PMID:
21447219
27.

Parents' perspectives on the unforeseen finding of a fetal sex chromosomal aneuploidy.

Pieters JJ, Kooper AJ, Eggink AJ, Verhaak CM, Otten BJ, Braat DD, Smits AP, van Leeuwen E.

Prenat Diagn. 2011 Mar;31(3):286-92. doi: 10.1002/pd.2707. Epub 2011 Feb 4.

PMID:
21294136
28.

Ear and hearing problems in relation to karyotype in children with Turner syndrome.

Verver EJ, Freriks K, Thomeer HG, Huygen PL, Pennings RJ, Alfen-van der Velden AA, Timmers HJ, Otten BJ, Cremers CW, Kunst HP.

Hear Res. 2011 May;275(1-2):81-8. doi: 10.1016/j.heares.2010.12.007. Epub 2010 Dec 10.

PMID:
21147207
29.

Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning.

Reus L, Zwarts M, van Vlimmeren LA, Willemsen MA, Otten BJ, Nijhuis-van der Sanden MW.

Neurosci Biobehav Rev. 2011 Jan;35(3):956-69. doi: 10.1016/j.neubiorev.2010.10.015. Epub 2010 Nov 4. Review.

30.

The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.

Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.

J Voice. 2011 Sep;25(5):602-10. doi: 10.1016/j.jvoice.2010.06.002. Epub 2010 Oct 25.

PMID:
20971614
31.

Adrenal function: A gold standard test for adrenal insufficiency in children?

Claahsen-van der Grinten HL, Otten BJ.

Nat Rev Endocrinol. 2010 Nov;6(11):605-6. doi: 10.1038/nrendo.2010.152. No abstract available.

PMID:
20962867
32.

Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.

Menke LA, Sas TC, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.

Horm Res Paediatr. 2011 Feb;75(2):115-22. doi: 10.1159/000319313. Epub 2010 Sep 3.

PMID:
20814189
33.

Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial.

Sas TC, de Ridder MA, Wit JM, Rotteveel J, Oostdijk W, Reeser HM, Otten BJ, de Muinck Keizer-Schrama SM.

Horm Res Paediatr. 2010;74(3):172-81. doi: 10.1159/000281323. Epub 2010 Apr 24.

PMID:
20424418
34.

Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.

Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.

Horm Res Paediatr. 2010;74(5):328-32. doi: 10.1159/000308891. Epub 2010 Apr 2.

PMID:
20357427
35.

The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.

Menke LA, Sas TC, Zandwijken GR, de Ridder MA, Stijnen T, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.

Clin Endocrinol (Oxf). 2010 Aug;73(2):212-9. doi: 10.1111/j.1365-2265.2010.03789.x. Epub 2010 Jan 23.

PMID:
20105186
36.

Growth in Noonan syndrome.

Otten BJ, Noordam C.

Horm Res. 2009 Dec;72 Suppl 2:31-5. doi: 10.1159/000243776. Epub 2009 Dec 22.

PMID:
20029234
37.

Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.

Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.

J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8.

PMID:
20061421
38.

The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.

Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM, Cohen-Kettenis PT.

Horm Behav. 2010 Mar;57(3):297-305. doi: 10.1016/j.yhbeh.2009.12.011. Epub 2010 Jan 4.

PMID:
20053349
39.

Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Claahsen-van der Grinten HL, Hermus AR, Otten BJ.

Int J Pediatr Endocrinol. 2009;2009:624823. doi: 10.1155/2009/624823. Epub 2009 Feb 26.

40.

[Psychosocial deprivation as a cause of growth retardation in children].

Trip-Hoving M, van Alfen-Van der Velden JA, Otten BJ.

Ned Tijdschr Geneeskd. 2009;153:A455. Dutch.

PMID:
19900333
41.

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16.

PMID:
19837938
42.

Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.

de Lind van Wijngaarden RF, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, van Leeuwen M, Haring DA, Bocca G, Mieke Houdijk EC, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Oct;94(10):3763-71. doi: 10.1210/jc.2009-0270. Epub 2009 Jul 21.

PMID:
19622627
43.

Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR.

Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):209-20. doi: 10.1016/j.beem.2008.09.007. Review.

PMID:
19500764
44.

The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, Joosten KF, van den Berg S, Otten BJ, de Jong FH, Sweep CG, de Weerd AW, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Jul;94(7):2387-93. doi: 10.1210/jc.2008-2808. Epub 2009 Apr 21.

PMID:
19383777
45.

A healthy, female chimera with 46,XX/46,XY karyotype.

Binkhorst M, de Leeuw N, Otten BJ.

J Pediatr Endocrinol Metab. 2009 Jan;22(1):97-102.

PMID:
19344081
46.

Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, de Klerk LW, Festen DA, Duivenvoorden HJ, Otten BJ, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Apr;94(4):1274-80. doi: 10.1210/jc.2008-1844. Epub 2009 Jan 21.

PMID:
19158197
47.

Case 2: A 6-year-old boy with precocious puberty (case presentation).

Mattheij MA, Otten BJ.

Acta Paediatr. 2009 Jan;98(1):6-7, 201-2. doi: 10.1111/j.1651-2227.2008.01117.x. No abstract available.

PMID:
19086939
48.

An adrenal rest tumour in the perirenal region in a patient with congenital adrenal hyperplasia due to congenital 3beta-hydroxysteroid dehydrogenase deficiency.

Claahsen-van der Grinten HL, Duthoi K, Otten BJ, d'Ancona FC, Hulsbergen-vd Kaa CA, Hermus AR.

Eur J Endocrinol. 2008 Oct;159(4):489-91. doi: 10.1530/EJE-08-0311. Epub 2008 Jul 22.

PMID:
18647821
49.

Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.

Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ.

Eur J Endocrinol. 2008 Sep;159(3):203-8. doi: 10.1530/EJE-08-0413. Epub 2008 Jun 18.

PMID:
18562489
50.

Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database.

Raaijmakers R, Noordam C, Karagiannis G, Gregory JW, Hertel NT, Sipilä I, Otten BJ.

J Pediatr Endocrinol Metab. 2008 Mar;21(3):267-73.

PMID:
18540254

Supplemental Content

Loading ...
Support Center